🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

40 results for “Biotech Pharmaceutical Co.,” Clear

  1. Nimotuzumab

    Biotech Pharmaceutical Co.,

    Solid Tumors

    phase 1 small molecule active

    1 trial

  2. Nimotuzumab and chemotherapy

    Biotech Pharmaceutical Co.,

    Non-small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  3. Pegfilgrastim

    Biotech Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  4. Peginterferon lambda

    Biotech Pharmaceutical Co.,

    Hepatitis C

    phase 1 mab completed

    1 trial

  5. TSB-9-W1

    Biotech Pharmaceutical Co.,

    Metastatic Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  6. Tuberculosis Vaccine

    Biotech Pharmaceutical Co.,

    Tuberculosis

    phase 1 mab completed

    1 trial

  7. 2wIPV+1sIPV

    Biotech Pharmaceutical Co.,

    Poliomyelitis

    approved mab active

    1 trial

  8. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial

  9. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  10. ANKASCIN 568-P Red yeast rice capsules

    Biotech Pharmaceutical Co.,

    Hyperlipidemias

    other active

    1 trial

  11. ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules

    Biotech Pharmaceutical Co.,

    Cognitive Functions Perceptual Disturbances

    other active

    1 trial

  12. Lactobacillus rhamnosus F-1

    Biotech Pharmaceutical Co.,

    Allergic Rhinitis

    other active

    1 trial

  13. Neomycin/ Dexameythasone/Xylometazoline

    Biotech Pharmaceutical Co.,

    Rhinosinusitis

    small molecule completed

    1 trial

  14. Oligo Fucoidan

    Biotech Pharmaceutical Co.,

    NSCLC Stage IV

    other terminated

    1 trial

  15. Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

    Biotech Pharmaceutical Co.,

    Diphtheria

    mab completed

    1 trial

  16. Umooze

    Biotech Pharmaceutical Co.,

    Benign Prostatic Hyperplasia

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources